UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
Marni graduated from the University of Florida with a BS degree in Psychology – Behavioral and Cognitive Neuroscience and a minor in Zoology. At UF, she was a Research Assistant for a Neurocognitive Lab studying addiction. She also coded qualitative data on the impact of COVID-19 on college students, created a scientific poster for an international conference and wrote a manuscript that is currently under review for publication. Marni was Clinic Manager at a Neuropsychology Clinic where she gained experience scoring and administering neuropsychological tests.
Ranjani graduated from the University of California, San Diego with a bachelor’s degree in cognitive science specializing in Clinical Aspects of Cognition. She is extremely interested in and passionate about neurodegenerative disease research, especially Alzheimer’s disease. She now works at the Memory and Aging Center in Dr. Rabinovici’s In Vivo Molecular Neuroimaging Lab.
Ms. Smith is the clinical research supervisor working directly with the Rabinovici Lab and the Alzheimer’s Disease Research Center. She works closely with both faculty and staff in monitoring operational issues, regulatory compliance and project development. Ms. Smith brings many years of experience in clinical and non-clinical trials across a variety of funding mechanisms and disciplines. Prior to coming to the Memory and Aging Center in April 2019, Ms.
Rebecca Snell graduated from UC Davis with a Bachelor of Science degree in Neurobiology, Physiology, and Behavior with an emphasis in Neurobiology and a minor in Psychology. She works as part of the Clinical Trials Team with Dr. Adam Boxer.
Karin (“Kari”) joined the Boxer Lab’s Clinical Trials team as a Project Manager in 2023. A San Francisco native (born at UCSF!), she has managed intervention research for over 15 years, the last ten aiming to reduce stress in family caregivers of people with dementia.
Dr. David N. Soleimani-Meigooni is a neurologist who cares for patients experiencing cognitive symptoms as a result of neurodegenerative diseases such as Alzheimer's disease.
In research, Soleimani-Meigooni focuses on advancing precision-medicine approaches to diagnosing Alzheimer's disease and other neurodegenerative diseases. He looks at using positron emission tomography (PET) to image amyloid-beta and tau (protein fragments that accumulate in the brains of people with the condition).
